+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Severe heart failure in consequence of late anthracycline-induced cardiotoxicity--case report



Severe heart failure in consequence of late anthracycline-induced cardiotoxicity--case report



Klinicka Onkologie 22(1): 34-37



Anthracyclines are known cardiotoxic agents. Anthracycline therapy increases the risk of long-term cardiac adverse effects in oncology patients. We report the case of a young male patient with severe congestive heart failure. The patient was treated for childhood acute myeloid leukemia by chemotherapy containing anthracyclines. Manifest dilated cardiomyopathy was developing ten years after the termination of chemotherapy with symptoms of left ventricular heart failure. Seventeen years following the end of cytostatic therapy the patient underwent heart transplantantation as ultimum refugium. Late cardiac complications may become a serious therapeutic problem. In such cases, the heart transplantation seems to be the only effective approach otherwise terminal forms of the heart failure.

(PDF emailed within 1 workday: $29.90)

Accession: 055739216

Download citation: RISBibTeXText

PMID: 19534438


Related references

Anthracycline-induced chronic cardiotoxicity and heart failure. Acta Oncologica 46(5): 576-580, 2007

Recovery from left ventricular dysfunction was associated with the early introduction of heart failure medical treatment in cancer patients with anthracycline-induced cardiotoxicity. Clinical Research in Cardiology, 2018

Late-onset anthracycline-induced cardiotoxicity. Medicina Clinica 133(8): 311-313, 2009

Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation 131(22): 1981-1988, 2015

Incidence, Time of Occurrence and Response to Heart Failure Therapy in Patients with Anthracycline Cardiotoxicity. Internal Medicine Journal: -, 2016

Modern Aspects Of Diagnosis And Treatment Of Heart Failure, As A Manifestation Of Anthracycline Cardiotoxicity (Review). Georgian Medical News 2018(278): 87-93, 2018

Cardiac re-synchronization therapy in a child with severe anthracycline-induced congestive heart failure and normal QRS duration. Journal of Heart and Lung Transplantation 26(12): 1333-1335, 2007

Letter by Patanè Regarding Article, "Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy". Circulation 133(4): E361-E361, 2016

Biomarkers and early detection of late onset anthracycline-induced cardiotoxicity in children. Hematology 17(3): 151-156, 2013

Letter by Gallucci and Simeon Regarding Article, "Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy". Circulation 133(4): E362-E362, 2016

Anthracycline-induced acute cardiotoxicity in adults treated for leukaemia. Analysis of the clinico-pathological aspects of documented acute anthracycline-induced cardiotoxicity in patients treated for acute leukaemia at the University Hospital of Zürich, Switzerland, between 1990 and 1996. Annals of Oncology 12(7): 963-966, 2001

Early and late anthracycline-induced cardiotoxicity in childhood: non-invasive evaluation of contractility in 116 patients. Giornale Italiano di Cardiologia 25(10): 1295-1305, 1995

Anthracycline-induced cardiotoxicity: report of fatal cases. Revista Medica del Instituto Mexicano del Seguro Social 54(3): 404-408, 2016

Effectiveness of the combination therapy with lisinopril, ivabradine and multivitamin supplementation in anthracycline-induced severe cardiotoxicity. International Journal of Cardiology 176(3): 1374-1376, 2015

Pulmonary arterial hypertension and chronic heart failure as dasatinib cardiotoxicity. A case report. Kardiologiia 57(S4): 53-60, 2019